{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:09:11Z","timestamp":1784225351121,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,16]]},"DOI":"10.7759\/cureus.112806","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:52:31Z","timestamp":1784224351000},"source":"Crossref","is-referenced-by-count":0,"title":["Migraine Headaches in a Pediatric Patient With SETD5-Related Neurodevelopmental Disorder and Inflammatory Comorbidities: A Case Report"],"prefix":"10.7759","author":[{"given":"Tareq","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Elyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44472-1","article-title":"Prevalence and trends of developmental disabilities among US children and adolescents aged 3 to 17\u00a0years, 2018-2021","volume":"13","author":"Li Q","year":"2023","unstructured":"Li Q, Li Y, Zheng J, et al.. Prevalence and trends of developmental disabilities among US children and adolescents aged 3 to 17\u00a0years, 2018-2021. Sci Rep. 2023, 13:17254. 10.1038\/s41598-023-44472-1","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37832","article-title":"SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression","volume":"170","author":"Szcza\u0142uba K","year":"2016","unstructured":"Szcza\u0142uba K, Brzezinska M, Kot J, et al.. SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression. Am J Med Genet A. 2016, 170:2322-7. 10.1002\/ajmg.a.37832","journal-title":"Am J Med Genet A"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13132","article-title":"Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance","volume":"93","author":"Powis Z","year":"2018","unstructured":"Powis Z, Farwell Hagman KD, Mroske C, et al.. Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance. Clin Genet. 2018, 93:752-61. 10.1111\/cge.13132","journal-title":"Clin Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2024.11.008","article-title":"Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder","volume":"54","author":"De Falco A","year":"2025","unstructured":"De Falco A, De Dominicis A, Trivisano M, et al.. Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder. Eur J Paediatr Neurol. 2025, 54:8-17. 10.1016\/j.ejpn.2024.11.008","journal-title":"Eur J Paediatr Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00757.x","article-title":"Development of a patient-based grading scale for PedMIDAS","volume":"24","author":"Hershey AD","year":"2004","unstructured":"Hershey AD, Powers SW, Vockell AL, LeCates SL, Segers A, Kabbouche MA. Development of a patient-based grading scale for PedMIDAS. Cephalalgia. 2004, 24:844-9. 10.1111\/j.1468-2982.2004.00757.x","journal-title":"Cephalalgia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.165","article-title":"Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome","volume":"23","author":"Kuechler A","year":"2015","unstructured":"Kuechler A, Zink AM, Wieland T, et al.. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome. Eur J Hum Genet. 2015, 23:753-60. 10.1038\/ejhg.2014.165","journal-title":"Eur J Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1761","article-title":"The diverse functions of histone lysine methylation","volume":"6","author":"Martin C","year":"2005","unstructured":"Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol. 2005, 6:838-49. 10.1038\/nrm1761","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.03.006","article-title":"De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability","volume":"94","author":"Grozeva D","year":"2014","unstructured":"Grozeva D, Carss K, Spasic-Boskovic O, et al.. De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability. Am J Hum Genet. 2014, 94:618-24. 10.1016\/j.ajhg.2014.03.006","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ng.909","article-title":"A copy number variation morbidity map of developmental delay","volume":"43","author":"Cooper GM","year":"2011","unstructured":"Cooper GM, Coe BP, Girirajan S, et al.. A copy number variation morbidity map of developmental delay. Nat Genet. 2011, 43:838-46. 10.1038\/ng.909","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-009-0684-z","article-title":"Molecular genetics of migraine","volume":"126","author":"de Vries B","year":"2009","unstructured":"de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM. Molecular genetics of migraine. Hum Genet. 2009, 126:115-32. 10.1007\/s00439-009-0684-z","journal-title":"Hum Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02240-8","article-title":"Epigenetics in migraine: the Junior Editorial Board Members' vision","volume":"27","author":"Scuteri D","year":"2025","unstructured":"Scuteri D, Labastida-Ramirez A, Rubio-Beltran E, Vuralli D, Onofri A. Epigenetics in migraine: the Junior Editorial Board Members' vision. J Headache Pain. 2025, 27:20. 10.1186\/s10194-025-02240-8","journal-title":"J Headache Pain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.02.008","article-title":"Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate","volume":"41","author":"Huang YS","year":"2009","unstructured":"Huang YS, Guilleminault C. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. Pediatr Neurol. 2009, 41:9-16. 10.1016\/j.pediatrneurol.2009.02.008","journal-title":"Pediatr Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(10)70268-1","article-title":"Anti-inflammatory plasma cytokines in children and adolescents with migraine headaches","volume":"62","author":"Pinheiro RC","year":"2010","unstructured":"Pinheiro RC, Dach F, Soare\u015f JDP, et al.. Anti-inflammatory plasma cytokines in children and adolescents with migraine headaches. Pharmacol Rep. 2010, 62:287-93. 10.1016\/S1734-1140(10)70268-1","journal-title":"Pharmacol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/508456-migraine-headaches-in-a-pediatric-patient-with-setd5-related-neurodevelopmental-disorder-and-inflammatory-comorbidities-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:52:32Z","timestamp":1784224352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/508456-migraine-headaches-in-a-pediatric-patient-with-setd5-related-neurodevelopmental-disorder-and-inflammatory-comorbidities-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.112806","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}